The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 2 study of pamiparib in the treatment of patients with locally advanced or metastatic HER2-negative breast cancer with germline BRCA mutation.
 
Tao Sun
No Relationships to Disclose
 
Yanxia Shi
No Relationships to Disclose
 
Jiuwei Cui
No Relationships to Disclose
 
Yongmei Yin
No Relationships to Disclose
 
Quchang Ouyang
No Relationships to Disclose
 
Qiang Liu
No Relationships to Disclose
 
Qingyuan Zhang
No Relationships to Disclose
 
Yiding Chen
No Relationships to Disclose
 
Shao Zhimin
No Relationships to Disclose
 
Shouman Wang
No Relationships to Disclose
 
Xiaojia Wang
No Relationships to Disclose
 
Zhongsheng Tong
No Relationships to Disclose
 
Yahua Zhong
No Relationships to Disclose
 
Min Yan
No Relationships to Disclose
 
Xi Yan
No Relationships to Disclose
 
Chuan Wang
No Relationships to Disclose
 
Haiyuan Yang
Employment - BeiGene
 
Miao Li
Employment - BeiGene
Stock and Other Ownership Interests - BeiGene
 
Xiao Xiang
Employment - BeiGene
Stock and Other Ownership Interests - BeiGene
 
Binghe Xu
Speakers' Bureau - AstraZeneca; Eisai; Pfizer; Roche
Research Funding - Jiangsu Hengrui Medicine (Inst)